Fusen Pharmaceutical Company Limited (HKG:1652)
Hong Kong
· Delayed Price · Currency is HKD 1.110
+0.040 (3.74%)
At close: Mar 10, 2026
HKG:1652 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 791 | 591 | 1,021 | 1,084 | 943 | 3,505 | Upgrade
|
| Market Cap Growth | 181.58% | -42.05% | -5.86% | 14.94% | -73.09% | -8.71% | Upgrade
|
| Enterprise Value | 1,106 | 964 | 1,249 | 1,351 | 1,059 | 3,321 | Upgrade
|
| Last Close Price | 1.07 | 0.80 | 1.37 | 1.43 | 1.23 | 4.51 | Upgrade
|
| PE Ratio | - | - | - | - | 46.17 | 42.09 | Upgrade
|
| PS Ratio | 3.00 | 1.71 | 1.64 | 1.95 | 1.99 | 6.06 | Upgrade
|
| PB Ratio | 2.09 | 1.51 | 1.65 | 1.57 | 1.17 | 4.48 | Upgrade
|
| P/TBV Ratio | 2.25 | 1.63 | 1.71 | 1.56 | 1.17 | 4.48 | Upgrade
|
| P/FCF Ratio | 6.59 | 7.64 | - | 11.07 | - | 31.22 | Upgrade
|
| P/OCF Ratio | 5.47 | 4.16 | - | 8.68 | 16.09 | 19.27 | Upgrade
|
| EV/Sales Ratio | 4.19 | 2.78 | 2.01 | 2.43 | 2.24 | 5.74 | Upgrade
|
| EV/EBITDA Ratio | - | - | 22.89 | 16.52 | 10.35 | 28.49 | Upgrade
|
| EV/EBIT Ratio | - | - | 52.87 | 26.31 | 13.09 | 34.21 | Upgrade
|
| EV/FCF Ratio | 9.21 | 12.45 | - | 13.79 | - | 29.57 | Upgrade
|
| Debt / Equity Ratio | 1.06 | 1.05 | 0.62 | 0.38 | 0.38 | 0.30 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 6.09 | 2.93 | 2.79 | 1.91 | Upgrade
|
| Debt / FCF Ratio | 3.33 | 5.34 | - | 2.69 | - | 2.10 | Upgrade
|
| Net Debt / Equity Ratio | 0.84 | 1.00 | 0.56 | 0.17 | 0.26 | -0.17 | Upgrade
|
| Net Debt / EBITDA Ratio | -22.35 | -11.30 | 6.33 | 1.45 | 2.02 | -1.16 | Upgrade
|
| Net Debt / FCF Ratio | 2.63 | 5.05 | -3.63 | 1.21 | -2.70 | -1.21 | Upgrade
|
| Asset Turnover | 0.19 | 0.25 | 0.42 | 0.38 | 0.31 | 0.40 | Upgrade
|
| Inventory Turnover | 0.97 | 0.97 | 1.73 | 2.11 | 1.48 | 2.20 | Upgrade
|
| Quick Ratio | 0.36 | 0.36 | 0.50 | 0.61 | 0.70 | 1.01 | Upgrade
|
| Current Ratio | 0.57 | 0.60 | 0.85 | 0.85 | 1.04 | 1.21 | Upgrade
|
| Return on Equity (ROE) | -40.49% | -40.58% | -6.18% | -5.46% | 2.53% | 9.35% | Upgrade
|
| Return on Assets (ROA) | -2.47% | -3.25% | 1.00% | 2.19% | 3.32% | 4.23% | Upgrade
|
| Return on Invested Capital (ROIC) | -8.02% | -8.34% | 2.69% | 5.88% | 6.72% | 11.83% | Upgrade
|
| Return on Capital Employed (ROCE) | -11.50% | -14.40% | 3.20% | 7.20% | 8.80% | 11.80% | Upgrade
|
| Earnings Yield | -24.24% | -33.97% | -3.92% | -3.61% | 2.17% | 2.38% | Upgrade
|
| FCF Yield | 15.18% | 13.09% | -9.33% | 9.03% | -8.12% | 3.20% | Upgrade
|
| Dividend Yield | - | - | - | - | 0.91% | 0.24% | Upgrade
|
| Payout Ratio | - | - | - | - | 49.90% | 4.48% | Upgrade
|
| Buyback Yield / Dilution | 0.76% | 1.60% | 0.53% | 1.85% | 2.51% | 1.59% | Upgrade
|
| Total Shareholder Return | 0.76% | 1.60% | 0.53% | 1.85% | 3.42% | 1.83% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.